(Q35069464)

6 August 2017

title

Should we treat depression with drugs or psychological interventions? A reply to Ioannidis (English)

1 reference

6 August 2017

John M Davis

1

1 reference

6 August 2017

William J Giakas

2

1 reference

6 August 2017

Jie Qu

3

1 reference

6 August 2017

Pavan Prasad

4

1 reference

6 August 2017

Stefan Leucht

5

1 reference

6 August 2017

publication date

10 May 2011

1 reference

Philosophy, Ethics, and Humanities in Medicine

6 August 2017

published in

1 reference

6 August 2017

volume

6

1 reference

6 August 2017

page(s)

8

1 reference

Efficacy of antidepressants: a re-analysis and re-interpretation of the Kirsch data

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123637

News coverage of FDA warnings on pediatric antidepressant use and suicidality

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123637

Relapse rates with long-term antidepressant drug therapy: a meta-analysis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123637

Decrease in suicide among the individuals treated with antidepressants: a controlled study of antidepressants in suicide, Sweden 1995-2005.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123637

Proper studies of selective serotonin reuptake inhibitors are needed for youth with depression

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123637

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123637

Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123637

Meta-analysis of major depressive disorder relapse and recurrence with second-generation antidepressants

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123637

Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123637

Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123637

A regulatory Apologia--a review of placebo-controlled studies in regulatory submissions of new-generation antidepressants

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123637

The impact of analytic method on interpretation of outcomes in longitudinal clinical trials

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123637

Effectiveness of antidepressants: an evidence myth constructed from a thousand randomized trials?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123637

Mixed-effects Poisson regression analysis of adverse event reports: the relationship between antidepressants and suicide

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123637

Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123637

Effectiveness of paroxetine in the treatment of acute major depression in adults: a systematic re-examination of published and unpublished data from randomized trials

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123637

Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123637

Fluoxetine and adult suicidality revisited: an updated meta-analysis using expanded data sources from placebo-controlled trials

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123637

Long-term treatment of depression with antidepressants: a systematic narrative review

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123637

Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123637

Severe depression and antidepressants: focus on a pooled analysis of placebo-controlled studies on agomelatine

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123637

Duloxetine: meta-analyses of suicidal behaviors and ideation in clinical trials for major depressive disorder

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123637

Temporal changes in suicide rates for persons treated and not treated with antidepressants in Denmark during 1995-1999.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123637

Attrition in randomized controlled clinical trials: methodological issues in psychopharmacology

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123637

The effect of correlation structure on treatment contrasts estimated from incomplete clinical trial data with likelihood-based repeated measures compared with last observation carried forward ANOVA.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123637

Enriched rater training using Internet based technologies: a comparison to traditional rater training in a multi-site depression trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123637

The Food and Drug Administration's deliberations on antidepressant use in pediatric patients.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123637

Promoting health and productivity for depressed patients in the workplace

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123637

Relationship of total health care charges to selective serotonin reuptake inhibitor utilization patterns including the length of antidepressant therapy--results from a managed care administrative claims database

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123637

Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123637

Duloxetine in the treatment of Major Depressive Disorder: a comparison of efficacy in patients with and without melancholic features

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123637

The efficacy of duloxetine: a comprehensive summary of results from MMRM and LOCF_ANCOVA in eight clinical trials

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123637

Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123637

Does elimination of placebo responders in a placebo run-in increase the treatment effect in randomized clinical trials? A meta-analytic evaluation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123637

Assessing Response Profiles from Incomplete Longitudinal Clinical Trial Data Under Regulatory Considerations

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123637

Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123637

Placebo response in studies of major depression: variable, substantial, and growing

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123637

The double-blind variable placebo lead-in period: results from two antidepressant clinical trials

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123637

Initial severity and differential treatment outcome in the National Institute of Mental Health Treatment of Depression Collaborative Research Program

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123637

Norepinephrine in depressive reactions. A review

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123637

The efficacy of psychotropic drugs: implications for power analysis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123637

Overview: maintenance therapy in psychiatry: II. Affective disorders

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123637

Altered dendritic spine density in animal models of depression and in response to antidepressant treatment

8 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1747-5341-6-8

Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1747-5341-6-8

Differential antidepressant symptom efficacy: placebo-controlled comparisons of duloxetine and SSRIs (fluoxetine, paroxetine, escitalopram).

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1747-5341-6-8

Evidence for the efficacy of duloxetine in treating mild, moderate, and severe depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1747-5341-6-8

Why do clinical trials fail? The problem of measurement error in clinical trials: time to test new paradigms?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1747-5341-6-8

Interview quality and signal detection in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1747-5341-6-8

Suicidality in pediatric patients treated with antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1747-5341-6-8

Relationship Between Antidepressant Medication Treatment and Suicide in Adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1747-5341-6-8

The sales of antidepressants and suicide rates in Norway and its counties 1980-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1747-5341-6-8

Cost of lost productive work time among US workers with depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1747-5341-6-8

Cost-effectiveness of practice-initiated quality improvement for depression: results of a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1747-5341-6-8

Psychosocial outcomes following long-term, double-blind treatment of chronic depression with sertraline vs placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1747-5341-6-8

Prenatal antibiotic treatment does not decrease group B streptococcus colonization at delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1747-5341-6-8

Placebo found equivalent to amoxicillin for treatment of acute bronchitis in Nairobi, Kenya: a triple blind, randomised, equivalence trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1747-5341-6-8

Efficacy of duloxetine and selective serotonin reuptake inhibitors: comparisons as assessed by remission rates in patients with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1747-5341-6-8

The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123637

Hippocampal volume reduction in major depression.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123637

Suicide trends among youths aged 10 to 19 years in the United States, 1996-2005

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123637

Short-term efficacy of tricyclic antidepressants revisited: a meta-analytic study

25 October 2018

1 reference

12 December 2020

Continuation and maintenance therapy in depression

1 reference

12 December 2020

Suicide and Primary Affective Disorders

1 reference

12 December 2020

Three-year outcomes for maintenance therapies in recurrent depression

1 reference

12 December 2020

Five-year outcome for maintenance therapies in recurrent depression

1 reference

12 December 2020

How long to onset of antidepressant action: a meta-analysis of patients treated with fluoxetine or placebo

1 reference

12 December 2020

Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs

1 reference

12 December 2020

Antidepressants and suicidal behavior: cause or cure?

1 reference

12 December 2020

Identifiers

DOI

10.1186/1747-5341-6-8

1 reference

Dimensions Publication ID

6 August 2017

0 references

1 reference

6 August 2017

1 reference